• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鸡滑液支原体免疫的起始:减毒活疫苗MS-H(Vaxsafe MS)与其野生型亲本菌株(86079/7NS)的比较。

Onset of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain (86079/7NS).

作者信息

Jones Jillian F, Whithear Kevin G, Scott Peter C, Noormohammadi Amir H

机构信息

School of Veterinary Science, The University of Melbourne, Werribee, Victoria, 3030, Australia.

出版信息

Avian Dis. 2006 Mar;50(1):82-7. doi: 10.1637/7428-083005R.1.

DOI:10.1637/7428-083005R.1
PMID:16617987
Abstract

The onset of protective immunity with MS-H was determined through experimental challenge and compared with the parent strain 86079/7NS. MS-H vaccinates and 86079/7NS inoculates were challenged at 1, 2, 3, 4, 5, and 6 wk after vaccination, then examined 2 wk after challenge for signs of respiratory disease. Serologic results indicated that 100% of MS-H vaccinates had antibodies to MS by 3 wk after vaccination and 100% of 86079/7NS inoculates were positive by 2 wk after inoculation. From 3 wk after vaccination, MS-H vaccinates had a significantly lower incidence of air sac lesions and, from 4 wk after vaccination, a significantly lower air sac lesion severity. In 86079/7NS-inoculated birds, a significantly lower incidence of air sac lesions was observed from 1 wk after inoculation, and air sac lesion severity was significantly lower than the unvaccinated controls at 3 wk after inoculation. It would appear that, under the conditions of this experiment, protective immunity elicited by MS-H appeared at 4 wk after vaccination, slightly later than the appearance of serum antibody. Although the MS-H vaccine was slower to establish protective immunity than 86079/7NS, there was no significant difference between the two strains by 4 wk after vaccination or inoculation.

摘要

通过实验攻毒确定了MS-H诱导的保护性免疫的起效情况,并与亲本菌株86079/7NS进行了比较。在接种后1、2、3、4、5和6周对接种MS-H疫苗的鸡和接种86079/7NS的鸡进行攻毒,然后在攻毒后2周检查呼吸道疾病症状。血清学结果表明,接种MS-H疫苗的鸡在接种后3周时100%产生了针对MS的抗体,接种86079/7NS的鸡在接种后2周时100%呈阳性。接种MS-H疫苗的鸡从接种后3周起气囊病变发生率显著降低,从接种后4周起气囊病变严重程度显著降低。在接种86079/7NS的鸡中,从接种后1周起观察到气囊病变发生率显著降低,接种后3周时气囊病变严重程度显著低于未接种疫苗的对照鸡。在本实验条件下,MS-H诱导的保护性免疫似乎在接种后4周出现,略晚于血清抗体的出现。虽然MS-H疫苗建立保护性免疫的速度比86079/7NS慢,但在接种或接种后4周时,这两种菌株之间没有显著差异。

相似文献

1
Onset of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain (86079/7NS).鸡滑液支原体免疫的起始:减毒活疫苗MS-H(Vaxsafe MS)与其野生型亲本菌株(86079/7NS)的比较。
Avian Dis. 2006 Mar;50(1):82-7. doi: 10.1637/7428-083005R.1.
2
Duration of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain, 86079/7NS.鸡滑液支原体的免疫持续时间:减毒活疫苗MS-H(Vaxsafe MS)与其野生型亲本菌株86079/7NS的比较。
Avian Dis. 2006 Jun;50(2):228-31. doi: 10.1637/7465-103005R.1.
3
Determination of the effective dose of the live Mycoplasma synoviae vaccine, Vaxsafe MS (strain MS-H) by protection against experimental challenge.通过预防实验性攻毒来确定活的鸡滑液囊支原体疫苗Vaxsafe MS(MS-H株)的有效剂量。
Avian Dis. 2006 Mar;50(1):88-91. doi: 10.1637/7429-083005R.1.
4
Mutation of oppF gene in the Mycoplasma synoviae MS-H vaccine strain and its implication for differential serological responses to vaccination versus field challenge.滑液支原体 MS-H 疫苗株中 oppF 基因突变及其对疫苗接种与田间攻毒后血清学反应差异的影响。
Vet Microbiol. 2019 Apr;231:48-55. doi: 10.1016/j.vetmic.2019.02.029. Epub 2019 Feb 22.
5
Quantification of the horizontal transmission of Mycoplasma synoviae in non-vaccinated and MS-H-vaccinated layers.鸡滑液支原体在未接种疫苗和接种MS-H疫苗蛋鸡中的水平传播定量研究。
Avian Pathol. 2017 Aug;46(4):346-358. doi: 10.1080/03079457.2017.1282602. Epub 2017 Mar 24.
6
Tracheal cellular immune response in chickens inoculated with Mycoplasma synoviae vaccine, MS-H or its parent strain 86079/7NS.鸡接种滑膜支原体疫苗 MS-H 及其亲本株 86079/7NS 后的气管细胞免疫反应。
Vet Immunol Immunopathol. 2022 Sep;251:110472. doi: 10.1016/j.vetimm.2022.110472. Epub 2022 Aug 4.
7
Evaluation of the non-temperature-sensitive field clonal isolates of the Mycoplasma synoviae vaccine strain MS-H.鸡滑液囊支原体疫苗株MS-H非温度敏感型田间克隆分离株的评估。
Avian Dis. 2003 Apr-Jun;47(2):355-60. doi: 10.1637/0005-2086(2003)047[0355:EOTNFC]2.0.CO;2.
8
Safety of a temperature-sensitive clone of Mycoplasma synoviae as a live vaccine.滑膜支原体温度敏感株作为活疫苗的安全性
Avian Dis. 1998 Oct-Dec;42(4):677-81.
9
Safety and efficacy of the Mycoplasma synoviae MS-H vaccine in turkeys.鸡滑液囊支原体MS-H疫苗在火鸡中的安全性和有效性。
Avian Dis. 2007 Jun;51(2):550-4. doi: 10.1637/0005-2086(2007)51[550:SAEOTM]2.0.CO;2.
10
Comparative genomic analyses of vaccine strain MS-H and its wild-type parent strain 86079/7NS: implications for the identification of virulence factors and applications in diagnosis of .疫苗株 MS-H 及其野生型亲本 86079/7NS 的比较基因组分析:对毒力因子鉴定及 诊断应用的启示
Avian Pathol. 2019 Dec;48(6):537-548. doi: 10.1080/03079457.2019.1637514. Epub 2019 Jul 19.

引用本文的文献

1
Construction and protective evaluation of a recombinant attenuated vaccine delivering antigens.一种递送抗原的重组减毒疫苗的构建及保护性评价
Virulence. 2025 Dec;16(1):2545554. doi: 10.1080/21505594.2025.2545554. Epub 2025 Aug 11.
2
Mechanisms of vaccine protection in chickens against challenge with virulent Mycoplasma synoviae.鸡接种疫苗抵抗强毒滑膜支原体攻击的保护机制。
Vet Res. 2025 Jul 9;56(1):146. doi: 10.1186/s13567-025-01571-3.